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doi:10.1016/j.ejvs.2008.09.025Abstract Interleukin-6 (IL-6) is associated with abdominal aortic aneurysm (AAA) develop-
ment and is an independent risk factor for cardiovascular mortality. We tested the hypothesis
that aneurysm repair reduces circulating IL-6 by comparing concentrations in patients with
large AAA awaiting repair (nZ 50) with patients having undergone open (nZ 34) or endovas-
cular (nZ 66) repair. Only open repair was associated with a significant reduction in IL-6
(pZ 0.025). These results suggest that AAAs remain biologically active following endovascular
repair. Aneurysm-derived IL-6 may have serious implications for cardiovascular health, and
attention should be directed to modifying cardiovascular risk factors in these patients, even
after successful aneurysm repair.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
The chronic inflammatory infiltrate that characterises
abdominal aortic aneurysms (AAA) is responsible for the
secretion of cytokines, which in turn stimulate proteolytic
enzymes to further contribute to the lesion. Interleukin-6
(IL-6) has emerged as a key cytokine implicated in this
process, with elevated circulating concentrations found in
patients with AAA compared to controls.1 Tissue culture
models revealed that aneurysms actively secrete IL-6 in8 725 3205; fax: þ44 208 725
n@stgeorges.nhs.uk (M.M.
ty for Vascular Surgery. Publishevitro1,2 and we have recently demonstrated that both
abdominal and thoracic aneurysms secrete IL-6 directly into
the circulation in proportion to the surface area of the
aneurysm.3 These findings have important clinical relevance
because elevated circulating IL-6 is an independent risk
factor for future myocardial infarction, cardiovascular and
all-cause mortality.2,4 This may be of particular relevance to
patients with AAA considering that the vast majority die
from cardiovascular causes unrelated to their aneurysm.5 It
is therefore plausible that IL-6 may play a far more critical
and insidious role in the long-term fate of the patient with
aneurysmal disease. We hypothesised that exclusion of the
aneurysm from the circulation, in the form of repair, would
reduce chronic circulating levels of IL-6. In this way aneu-
rysm repair might confer benefit to patients alongside
rupture prevention, by reducing overall cardiovascular risk.d by Elsevier Ltd. All rights reserved.
Figure 1 Box and whisker plot demonstrating circulating
interleukin-6 in AAA patients with unrepaired and repaired
(endovascular (EVR) and open) aneurysms. Whiskers represent
data within 1.5 IQR of the lower and upper quartiles. Mild
outliers are represented by dots and two extreme outliers are
not shown (unrepaired 114 pg/ml and EVAR 28 pg/ml).
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The study cohort consisted of three groups of patients;
those with large unrepaired AAA awaiting scheduled repair
(nZ 50), and those that had undergone aneurysm repair in
the past (endovascular (EVAR), nZ 66 and open, nZ 34).
Patient demographics are displayed in Table 1. The Local
Research Ethics Committee approved the study, and
patients gave written informed consent. A venous blood
sample was obtained from the antecubital fossa and plasma
IL-6 concentrations were measured in duplicate using
a Fluorokine assay. Data did not conform to Gaussian
distribution and a KruskaleWallis test with Dunn’s multiple
comparison was used to compare across the three groups.
ManneWhitney was utilised to determine the level of
significance between groups.
Results
There was a significant difference in IL-6 when comparing
the unrepaired group to the post-repair groups (unrepaired
5.4 pg/ml (3.9e8.1) vs EVAR 5.9 pg/ml (3.7e6.8) vs open
4.2 pg/ml (2.2e6.1), pZ 0.049). Open repair was associ-
ated with significantly lower concentrations of circulating
IL-6 compared to EVAR (pZ 0.03) and unrepaired AAA
(pZ 0.025, Fig. 1). There was no significant difference in
IL-6 between the unrepaired and EVAR groups (pZ 0.66).
Discussion
Aneurysmal aorta secretes more interleukin-6 in vitro than
healthy and atherosclerotic tissues,1,2 and this is reflected
in higher circulating concentrations in AAA patients.1 In
addition, these levels correlate with aneurysm diameter1,2
with in vivo evidence suggesting that IL-6 is secreted by the
aneurysm itself.2,3 As an independent risk factor for
cardiovascular and all-cause mortality2,4 it is plausible thatTable 1 Patient demographics.
Unrepaired
(nZ 50)
EVAR
(nZ 66)
Open
(nZ 34)
p-Value*
Age (mean) 72.8 1.2 74.0 0.8 73.4 1.0 NSy
Sex (male) 92% (46) 90% (60) 88% (30) NS
Hypertension 78% (39) 80% (53) 88% (30) NS
Ischaemic
heart disease
56% (28) 53% (35) 59% (20) NS
Cerebrovascular
disease
16% (8) 14% (9) 18% (6) NS
Peripheral
vascular
disease
14% (7) 8% (5) 9% (3) NS
Diabetes 12% (6) 14% (9) 16% (7) NS
Statin 82% (41) 88% (58) 79% (27) NS
Aspirin 86% (43) 88% (58) 79% (27) NS
Smoker 90% (45) 89% (59) 92% (31) NS
y Continuous data displayed as mean S.E.M, statistical
analysis by 1-way ANOVA.
* Categorical data displayed as % (absolute values), statistical
analysis by c2 test.these elevated concentrations of IL-6 contribute to the high
cardiovascular mortality observed at all stages of the
disease.5 We have demonstrated that open repair, but not
EVAR, reduces circulating IL-6 levels. Although expansion is
modified by EVAR, subsequent natural history of the aneu-
rysm remains inadequately defined, and our findings
suggest that it may remain biologically active. During open
repair thrombus is removed, retrograde bleeding halted
and the sac fully excluded from the circulation. However,
following EVAR the complex cellular milieu constituting
aneurysms remains in-situ, providing several possible cell-
types responsible for IL-6 secretion. Endoleaks may provide
an additional contribution to continued aneurysm patho-
physiology, but were excluded from this study. Large trials
have demonstrated that the initial peri-operative survival
advantage that EVAR exhibits over open repair is subse-
quently cancelled out by an excess of extra-aortic cardio-
vascular mortality.5 If EVAR patients are at increased risk
from cardiovascular morbidity due to the continued pres-
ence of an aneurysm, then attention should be directed to
modifying cardiovascular risk factors. Therefore smoking
cessation, combined with the appropriate use of statins,
anti-hypertensives and anti-platelets is just as essential in
patients with a past history of aneurysm repair as those
currently with an aneurysm.
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